Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers.
Mollyn Shew
Advertisement
Articles by Mollyn Shew
Advertisement
Latest Updated Articles
Dallas Nephrology Associates’ Journey to Value-Based CareDecember 10th 2024
Advertisement
Advertisement
Trending on AJMC
1
AI Chatbots Score Below 28% on Colorectal Cancer Questions
2
5 Notable FDA Approvals From the First Half of 2026
3
New Survey Highlights Quality-of-Life Benefits of Dry Eye Disease Treatment
4
Michigan Cyclospora Outbreak Surpasses 1500 Cases as Investigation Continues
5